Maolac 2.0: Start-up looks to fungi and plant side streams for breast milk protein biosimilarity

Maolac no longer wants to be thought of as ‘the colostrum company’, but a biotech championing biofunctional proteins from both animal and non-animal sources, CEO Maya Ashkenazi explains.

Related Keywords

Spain ,Israel ,Jerusalem ,Israel General ,Eli Lerner ,Ariel Orbach ,Maya Ashkenaz ,Maya Ashkenazi ,European Commission ,Ourcrowd Global Investor Summit ,Self Affirmed ,Novel Foods ,Business ,Dairy ,Tart Ups And Disruptors ,Food Tech ,Iet And Health ,Lternative Proteins ,Ustainability ,Proteins ,Colostrum ,Bovine Colostrum ,